Physician RSV Resources

Influenza and respiratory illness season is upon us. We are aware of rising rates of infection, severe illness, and hospitalization among our pediatric populations in Iowa, particularly with RSV. The American Academy of Pediatrics has released a number of resources to assist providers in managing patient populations and workforce considerations during this time of increasing rates.

Compounding the rise in pediatric respiratory illness is a nationwide amoxicillin shortage. IMS is engaging with health system partners and health department leadership to assist in system-wide strategies to help mitigate the impact of this shortage. In the interim, AAP has provided this guidance for antibiotic options in lieu of amoxicillin availability.


Amoxicillin Shortage and Alternatives

Amoxicillin Shortage: Antibiotic Options for Common Pediatric Conditions


Updated AAP Interim Guidance on RSV, Surge and AAP RSV Resources

The AAP offers updated recommendations for caring for patients during surges in volume in all practice settings, including ambulatory care, community hospitals, and tertiary or children's hospitals. AAP has also updated its interim guidance on the use of palivizumab prophylaxis, including the option to offer more than 5 doses.

The AAP has several resources for health care professionals and parents related to RSV:


The Iowa Medical  Society is a 501(c)6 non-profit organization. 515 E Locust St. Ste. 400 50309

Powered by Wild Apricot Membership Software